Amphotropic retrovirus packaging cell line, process for its production and use thereof
AssigneeRoche Diagnostics GmbH
InventorsClaudio Bordignon, Bernhard Goller, Ruediger Rueger, Georg Tiefenthaler
Life of this patent
Estimating the term…
Abstract
A titer of retroviral vectors of at least about 107 colony-forming units/ml cell culture supernatants is obtained using an amphotropic retroviral packaging cell line which contains functional gag, pol and env genes integrated into the genome in which the expression of the genes gag and pol is regulated independently of the expression of the env genes, wherein the genome of the said cell line contains one or two functionally active env genes.
Claims4
An amphotropic retroviral packaging cell line, each packaging cell containing exactly one functional gag gene, exactly one functional pol gene and exactly two functional env genes, the genes being integrated into the genome in such a manner that the expression of the gag and pol genes is regulated independently of the expression of the env genes and a titre of at least 107 colony-forming units/ml cell culture supernatant is achieved by the packaging cell line when packaging a retroviral vector.
A process for producing an amphotropic retroviral packaging cell line, which comprises transfecting a eukaryotic cell with an env helper plasmid containing a selection gene and a gag/pol helper plasmid containing a selection gene, identifying the transfected cells on the basis of the selection gene, and isolating those cells which contain two functionally active env genes.
The packaging cell line DSM ACC 2235.
A process for the production of a retroviral vector, which comprises (i) transfecting a eukaryotic cell with an env helper plasmid containing a selection gene and a gag/pol helper plasmid containing a selection, (ii) identifying the transfected cells on the basis of the selection gene, (iii) isolating those cells which contain two functionally active env genes, (iv) transfecting the isolated cells with a vector genome which contains one or more heterologous genes for the virus but contains no functionally active retroviral structural genes, (v) culturing the cells, and (vi) isolating the retroviral vector from the culture supernatant.
Dependencies are inferred from the claim text.